ALIGNMT AI
Category: AI in Healthcare
ALIGNMT AI offers a compliance assurance and risk mitigation platform tailored for healthcare AI systems. ALIGNMT AI was founded in 2023. The company is led by Andreea Bodnari. Based in New York, USA. Team size: 2-10. Total funding raised: $6.5M. Latest round: Seed. Key investors include AIX Ventures, Sancus Ventures, Alumni Ventures, Dent Capital.
- Founded
- 2023
- Headquarters
- New York, USA
- Team size
- 2-10
- Total funding
- $6.5M
Value proposition
Enabling healthcare organizations to safely adopt and scale AI by automating compliance, managing risks, and ensuring ethical standards to minimize liability and accelerate innovation.
Products and solutions
AI Compliance and Risk Management SaaS Platform
Unique value
Focused exclusively on healthcare AI governance with a platform that automates compliance and streamlines quality reporting for trustworthy healthcare AI.
Target customer
Healthcare organizations, including payers and providers, developing or deploying AI solutions.
Industries served
Healthcare
Technology advantage
Automates compliance and risk management, addressing a key challenge in healthcare AI adoption, enabling faster innovation and cost reduction through comprehensive risk management.
How they differentiate
ALIGNMT AI specializes in AI-specific compliance and risk management for healthcare, offering purpose-built tools to monitor, audit, and manage risks associated with AI and ML models unlike broader healthcare GRC solutions.
Main competitors
RLDatix, ProviderTrust, Radar Healthcare
Key partnerships
Collaboration with MSK Innovation Hub at Memorial Sloan Kettering Cancer Center to pilot AI governance platform for oncology (Oct 2025), Refined platform with healthcare customers since 2023
Notable customers
Memorial Sloan Kettering Cancer Center (MSK Innovation Hub)
Major milestones
Founded in 2024, Raised $6.5M in Seed funding, Launched AI governance platform for healthcare AI compliance and risk mitigation
Growth metrics
Specific growth metrics are not publicly available as a seed-stage startup founded in 2024.
Market positioning
Positioned as foundational infrastructure for trustworthy, compliant healthcare AI, serving healthcare organizations and AI developers navigating regulatory landscapes.
Geographic focus
Based in New York, USA with a primary focus on the North American healthcare market.
Patents and IP
No publicly available patent information.
About Andreea Bodnari
Previously a Principal AI/ML Scientist at UnitedHealth Group and a Senior Research Scientist at Google. She earned her PhD from MIT, specializing in cognitive AI systems.
Official website: https://www.alignmt.ai